{"log_id": 4927441428493169815, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.002796, "average": 0.978542, "min": 0.765719}, "location": {"width": 450, "top": 176, "height": 26, "left": 177}, "words": "切监测、目前尚未对严重肝功能障碍患者进行研究"}, {"probability": {"variance": 0.005625, "average": 0.958699, "min": 0.700945}, "location": {"width": 806, "top": 213, "height": 28, "left": 178}, "words": "肾功能损害:对轻度肾功能损害患者(肌酐清除率=51-80ml分 Cockroft和ault,计算公"}, {"probability": {"variance": 0.019935, "average": 0.934089, "min": 0.371851}, "location": {"width": 809, "top": 254, "height": 29, "left": 175}, "words": "式详见下文])不建议调整卡培他滨的起始剂量:对中度锋功能损害患者(基线肌清除率"}, {"probability": {"variance": 0.019774, "average": 0.933169, "min": 0.384131}, "location": {"width": 803, "top": 294, "height": 27, "left": 181}, "words": "30-50ml/分),当用于单药化疗或与多西紫杉醇联化疗时,建议卡培他滨起始剂量藏为标"}, {"probability": {"variance": 0.012555, "average": 0.951134, "min": 0.486791}, "location": {"width": 813, "top": 334, "height": 28, "left": 173}, "words": "准剂量的75%从1250mg/m2,每日2次减为950mg/m2一天2次见【药代动力学】:特"}, {"probability": {"variance": 0.0099, "average": 0.952447, "min": 0.571343}, "location": {"width": 805, "top": 374, "height": 26, "left": 180}, "words": "殊人群)。患者出现2级到4级不良事件(见【注意事项】)后相应的削量调整建议根据表"}, {"probability": {"variance": 0.007714, "average": 0.980374, "min": 0.437825}, "location": {"width": 810, "top": 412, "height": 28, "left": 174}, "words": "3和表4的要求进行。对肾功能中度受损患者起始剂量的调整建议既应用手卡培他滨单药"}, {"probability": {"variance": 0.01568, "average": 0.957299, "min": 0.490947}, "location": {"width": 449, "top": 453, "height": 24, "left": 176}, "words": "治疗,也再应用于卡培他滨和多西紫杉醇联治疗"}, {"probability": {"variance": 0.036478, "average": 0.838704, "min": 0.560896}, "location": {"width": 193, "top": 493, "height": 23, "left": 178}, "words": " Cockroft和Gaut方程"}, {"probability": {"variance": 0.05523, "average": 0.699805, "min": 0.375008}, "location": {"width": 229, "top": 534, "height": 24, "left": 607}, "words": "4一年龄【岁])韩重k】"}, {"probability": {"variance": 0.016686, "average": 0.918261, "min": 0.466698}, "location": {"width": 390, "top": 567, "height": 28, "left": 405}, "words": "男性肌酐清除率(72)(血清肌酐mg/di"}, {"probability": {"variance": 0.042691, "average": 0.883019, "min": 0.379038}, "location": {"width": 342, "top": 608, "height": 25, "left": 410}, "words": "女性肌酐清除率0.85×男性肌清除率"}, {"probability": {"variance": 0.000174, "average": 0.992009, "min": 0.942264}, "location": {"width": 810, "top": 652, "height": 26, "left": 176}, "words": "老年患者:卡培他滨单药治疗时,不需要对起始剂量进行调整。与年轻患者相比,卡培他滨"}, {"probability": {"variance": 0.002352, "average": 0.980895, "min": 0.763982}, "location": {"width": 810, "top": 692, "height": 26, "left": 175}, "words": "在老年患者(>60岁)中的不良反应更为显著:卡培他滨与奥沙利铂联合使用时,老年患者"}, {"probability": {"variance": 0.00418, "average": 0.984199, "min": 0.603357}, "location": {"width": 790, "top": 730, "height": 27, "left": 195}, "words": "65岁)与年轻患者相比出现更多的3~4度不良反应以及导致停药的不良反应。医生应"}, {"probability": {"variance": 2.4e-05, "average": 0.99681, "min": 0.983038}, "location": {"width": 351, "top": 770, "height": 27, "left": 173}, "words": "该密切监测卡培他滨对老年患者的作用"}, {"probability": {"variance": 5e-06, "average": 0.998402, "min": 0.991727}, "location": {"width": 770, "top": 809, "height": 26, "left": 215}, "words": "当卡培他滨与多西他赛联合使用时,在60岁及以上的患者中可观察到3度或4度药物"}, {"probability": {"variance": 0.011894, "average": 0.959789, "min": 0.465957}, "location": {"width": 811, "top": 848, "height": 27, "left": 173}, "words": "相关性不良事件的发生率升高。因此,对于60岁及以上接受卡培他滨加多西他赛联合治疗"}, {"probability": {"variance": 0.010355, "average": 0.967021, "min": 0.535986}, "location": {"width": 425, "top": 889, "height": 26, "left": 174}, "words": "的患者,建议将卡培他滨的起始剂量降低至759"}, {"probability": {"variance": 0.000981, "average": 0.986146, "min": 0.812431}, "location": {"width": 774, "top": 928, "height": 26, "left": 216}, "words": "与顺铂联合应用,卡培他滨的推荐剂量是1000mg/m2,1天2次,治疗2周后停药1"}, {"probability": {"variance": 0.004619, "average": 0.963706, "min": 0.674606}, "location": {"width": 811, "top": 967, "height": 26, "left": 174}, "words": "周。顺铂剂量80mg/m2,于每3周疗程的第1天,静脉滴注,2小时滴完。首剂卡培他滨于"}, {"probability": {"variance": 0.003689, "average": 0.980109, "min": 0.715771}, "location": {"width": 423, "top": 1005, "height": 26, "left": 173}, "words": "第一天晚间服用,最后一剂于第15天早晨服用"}, {"probability": {"variance": 0.000634, "average": 0.989989, "min": 0.876456}, "location": {"width": 770, "top": 1045, "height": 25, "left": 215}, "words": "接受卡培他滨和顺铂联合治疗的患者,在给予顺铂前,需按照顺铂的产品说明书给予"}, {"probability": {"variance": 2e-06, "average": 0.998781, "min": 0.994959}, "location": {"width": 208, "top": 1083, "height": 25, "left": 173}, "words": "充分的水化和止吐治疗"}, {"probability": {"variance": 0.000398, "average": 0.994193, "min": 0.877362}, "location": {"width": 772, "top": 1120, "height": 27, "left": 215}, "words": "与顺铂联合,出现了主治医生考虑的并不严重或无生命危险的毒副作用,如:脱发、食"}, {"probability": {"variance": 0.001038, "average": 0.991324, "min": 0.794366}, "location": {"width": 810, "top": 1159, "height": 27, "left": 175}, "words": "欲改变、指甲变色等,可以继续按始剂量治疗,而不需减量或中断。如需要进一步关于顺铂"}, {"probability": {"variance": 5e-06, "average": 0.998256, "min": 0.991969}, "location": {"width": 272, "top": 1201, "height": 25, "left": 173}, "words": "的资料请查询顺铂说明书信息"}, {"probability": {"variance": 0.017412, "average": 0.941022, "min": 0.548565}, "location": {"width": 209, "top": 1241, "height": 26, "left": 177}, "words": "对于血液毒性剂量调整"}, {"probability": {"variance": 0.003742, "average": 0.982987, "min": 0.658936}, "location": {"width": 772, "top": 1279, "height": 27, "left": 214}, "words": "如果疗程开始时,患者的绝对中性粒细胞计数(ANC)大于1000×10/,血小板计数大于"}, {"probability": {"variance": 0.02456, "average": 0.941079, "min": 0.398098}, "location": {"width": 811, "top": 1319, "height": 26, "left": 176}, "words": "1000010^/,可以开始新的3周疗程否则,治疗需要推迟直到血液指标恢复后。血液毒"}, {"probability": {"variance": 1.1e-05, "average": 0.997644, "min": 0.988346}, "location": {"width": 268, "top": 1357, "height": 26, "left": 175}, "words": "性剂量调整的详细指导见表5"}, {"probability": {"variance": 0.000403, "average": 0.990552, "min": 0.906325}, "location": {"width": 732, "top": 1396, "height": 27, "left": 215}, "words": "表5.卡培他滨(X)联合顺铂(P)在计划治疗期间根据血液毒性进行的剂量调整方案"}, {"probability": {"variance": 0.000381, "average": 0.986844, "min": 0.929296}, "location": {"width": 223, "top": 1439, "height": 21, "left": 178}, "words": "中性粒细胞绝对值ANC计数"}, {"probability": {"variance": 0.004679, "average": 0.962577, "min": 0.826066}, "location": {"width": 90, "top": 1439, "height": 21, "left": 536}, "words": "血小板计数"}, {"probability": {"variance": 0.00026, "average": 0.985768, "min": 0.951655}, "location": {"width": 277, "top": 1439, "height": 22, "left": 689}, "words": "卡培他滨和顺铂在治疗重新开始时的"}, {"probability": {"variance": 0.030167, "average": 0.847197, "min": 0.513302}, "location": {"width": 42, "top": 1479, "height": 20, "left": 282}, "words": "10/1)"}, {"probability": {"variance": 0.00956, "average": 0.909115, "min": 0.745732}, "location": {"width": 37, "top": 1479, "height": 20, "left": 575}, "words": "0/1)"}, {"probability": {"variance": 0.012998, "average": 0.874423, "min": 0.687889}, "location": {"width": 70, "top": 1479, "height": 20, "left": 796}, "words": "剂量调整"}, {"probability": {"variance": 0.006352, "average": 0.961452, "min": 0.783303}, "location": {"width": 67, "top": 1519, "height": 20, "left": 504}, "words": "100.00"}, {"probability": {"variance": 0.004282, "average": 0.933155, "min": 0.757922}, "location": {"width": 196, "top": 1516, "height": 21, "left": 705}, "words": "100%起始削量,无需延退"}, {"probability": {"variance": 0.002695, "average": 0.971031, "min": 0.799398}, "location": {"width": 200, "top": 1543, "height": 24, "left": 697}, "words": "100%起始剂量,无需延迟"}], "language": 3}